Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites
2001

Rare TP53 Mutations in Finnish Breast Cancer Families

publication Evidence: moderate

Author Information

Author(s): Rapakko K, Allinen M, Syrjäkoski K, Vahteristo P, Huusko P, Vähäkangas K, Eerola H, Kainu T, Kallioniemi O-P, Nevanlinna H, Winqvist R

Primary Institution: University of Oulu/Oulu University Hospital, Oulu, Finland

Hypothesis

Are germline TP53 mutations present in Finnish breast cancer families?

Conclusion

The study found that TP53 mutations are rare and occur only at specific sites in families with hereditary breast cancer.

Supporting Evidence

  • The study represents the largest survey of the entire protein-encoding portion of TP53.
  • Mutations were only found at conserved domains in families meeting Li-Fraumeni criteria.
  • TP53 mutations explain only a small fraction of hereditary breast cancer cases.

Takeaway

This study looked for specific gene changes in families with breast cancer and found that these changes are very uncommon.

Methodology

The study screened for germline TP53 mutations in Finnish BRCA1 and BRCA2 mutation-negative families.

Limitations

The study only focused on families meeting specific criteria and may not represent all breast cancer cases.

Participant Demographics

Finnish families with breast cancer, specifically those negative for BRCA1 and BRCA2 mutations.

Digital Object Identifier (DOI)

10.1054/bjoc.2000.1530

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication